Eli Lilly's stock jumps after pharma giant beats with profit, raises guidance [MarketWatch]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MarketWatch
Eli Lilly's stock jumps after profit and revenue beats, raised guidance Shares of Eli Lilly & Co. LLY, +0.42% rallied 1.5% in premarket trading Tuesday, after the drug maker reported a second-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income was $1.33 billion, or $1.44 a share, after a loss of $259.9 million, or 25 cents a share, in the same period a year ago. Excluding non-recurring items, adjusted EPS rose to $1.50 from $1.48, above the FactSet consensus of $1.45. Revenue rose 1% to $5.64 billion, beating the FactSet consensus of $5.58 billion. Trulicity sales climbed 32% to $1.03 billion, just below the FactSet consensus of $1.08 billion, while Humalog sales fell 12% to $677.6 million but beat expectations of $659.7 million. For 2019, the company raised its adjusted EPS guidance range to $5.67 to $5.77 from $5.60 to $5.70. The stock has lost 6.1% year to date through Monday, while the SPDR Health Care Select Sector ETF XLV, +0.41%
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk comes under Senate probe over pricing for weight loss drugs [Seeking Alpha]Seeking Alpha
- Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- 4 Large Drug Stocks to Hold on to Amid Industry Challenges [Yahoo! Finance]Yahoo! Finance
- Wegovy Access Expands to Millions in US on Medicare, Study Finds [BNN Bloomberg (Canada)]BNN Bloomberg
- Biogen Profit Beats Street Estimates as Cost-Cutting Takes Hold [BNN Bloomberg (Canada)]BNN Bloomberg
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website